BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29450978)

  • 21. Staging of intrahepatic cholangiocarcinoma.
    Nathan H; Pawlik TM
    Curr Opin Gastroenterol; 2010 May; 26(3):269-73. PubMed ID: 20179593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.
    Cheng Z; Lei Z; Si A; Yang P; Luo T; Guo G; Zhou J; Wang X; Li Z; Xia Y; Li J; Wang K; Yan Z; Wei W; Hartmann D; Hüser N; Lau WY; Shen F
    HPB (Oxford); 2019 Dec; 21(12):1656-1666. PubMed ID: 31307889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification.
    Jonas S; Thelen A; Benckert C; Biskup W; Neumann U; Rudolph B; Lopez-Häänninen E; Neuhaus P
    Ann Surg; 2009 Feb; 249(2):303-9. PubMed ID: 19212186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system.
    Nishio H; Nagino M; Oda K; Ebata T; Arai T; Nimura Y
    Langenbecks Arch Surg; 2005 Aug; 390(4):319-27. PubMed ID: 16001285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.
    Sakamoto Y; Kokudo N; Matsuyama Y; Sakamoto M; Izumi N; Kadoya M; Kaneko S; Ku Y; Kudo M; Takayama T; Nakashima O;
    Cancer; 2016 Jan; 122(1):61-70. PubMed ID: 26430782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
    Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
    Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma.
    Juntermanns B; Kaiser GM; Orth L; Reis H; Jaradat D; Sydor S; Buechter M; Kasper S; Mathé Z; Sotiropoulos GC; Baba HA; Canbay A; Paul A; Fingas CD
    Eur J Med Res; 2018 Jun; 23(1):29. PubMed ID: 29859128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma.
    Zhang XF; Xue F; He J; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    HPB (Oxford); 2021 Sep; 23(9):1456-1466. PubMed ID: 33814298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
    Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new clinically based staging system for perihilar cholangiocarcinoma.
    Chaiteerakij R; Harmsen WS; Marrero CR; Aboelsoud MM; Ndzengue A; Kaiya J; Therneau TM; Sanchez W; Gores GJ; Roberts LR
    Am J Gastroenterol; 2014 Dec; 109(12):1881-90. PubMed ID: 25384902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Chen Y; Weng S
    J Gastrointest Surg; 2021 Aug; 25(8):1989-1999. PubMed ID: 33140321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
    Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
    Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A proposed staging system for intrahepatic cholangiocarcinoma.
    Nathan H; Aloia TA; Vauthey JN; Abdalla EK; Zhu AX; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2009 Jan; 16(1):14-22. PubMed ID: 18987916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma.
    Zhu Y; Zhu Y; Cai F; Zhao J; Liu F
    Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.